Detalhe da pesquisa
1.
AATF/Che-1 localizes to paraspeckles and suppresses R-loops accumulation and interferon activation in Multiple Myeloma.
EMBO J
; 41(22): e109711, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929179
2.
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim.
Ann Hematol
; 103(3): 947-956, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189833
3.
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?
Int J Mol Sci
; 20(6)2019 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30893777
4.
Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
Transfusion
; 58(5): 1143-1148, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446445
5.
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Am J Hematol
; 92(10): 1037-1046, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675513
6.
Ponatinib Induces a Persistent Molecular Response and Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia with a T315I Mutation following Early Relapse after Allogeneic Transplant.
Chemotherapy
; 62(1): 58-61, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27618144
7.
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.
Ann Hematol
; 95(7): 1059-65, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091349
8.
Prevention of Bortezomib-Induced Peripheral Neuropathy in Newly Multiple Myeloma Patients Using Nervonic Acid, Curcuma Rizoma, and L-Arginine Compound: A Pilot Study.
Integr Cancer Ther
; 21: 15347354221114142, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866451
9.
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group.
EJHaem
; 3(1): 121-128, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846211
10.
Flow cytometry characterization in central nervous system and pleural effusion multiple myeloma infiltration: an Italian national cancer institute experience.
Br J Haematol
; 172(6): 980-2, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26081466
11.
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network.
Br J Haematol
; 169(2): 293-6, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25371286
12.
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma.
Blood Adv
; 4(22): 5616-5630, 2020 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186461
13.
The Effect of Docosahexaenoic Acid and α-Lipoic Acid as Prevention of Bortezomib-Related Neurotoxicity in Patients With Multiple Myeloma.
Integr Cancer Ther
; 18: 1534735419888584, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31868025
14.
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease.
Leukemia
; 38(4): 877-882, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368441
15.
Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary Data.
Integr Cancer Ther
; 17(4): 1115-1124, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295079
16.
The usefulness of sLORETA in evaluating the effect of high-dose ARA-C on brain connectivity in patients with acute myeloid leukemia: an exploratory study.
Funct Neurol
; 22(4): 195-200, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29306356
17.
Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas.
Leukemia
; 36(2): 588-590, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545184
18.
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry.
Mediterr J Hematol Infect Dis
; 9(1): e2017046, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698789
19.
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide.
Blood Cancer J
; 12(9): 132, 2022 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071048
20.
Effect of high dose cytosine arabinoside on quantitative EEG in patients with acute myeloid leukemia.
Cogn Neurodyn
; 10(2): 185-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27066155